These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11143319

  • 1. Medical treatment of peripheral artery occlusive disease (PAOD).
    Clement DL.
    Acta Chir Belg; 2000; 100(5):190-3. PubMed ID: 11143319
    [Abstract] [Full Text] [Related]

  • 2. Outpatient rehabilitation in patients with coronary artery and peripheral arterial occlusive disease.
    Jeger RV, Rickenbacher P, Pfisterer ME, Hoffmann A.
    Arch Phys Med Rehabil; 2008 Apr; 89(4):618-21. PubMed ID: 18373990
    [Abstract] [Full Text] [Related]

  • 3. Quality of life and arterial endovascular intervention by means of balloon angioplasty.
    Slovacek L, Slovackova B, Chovanec V, Jebavy L.
    Int Angiol; 2008 Oct; 27(5):396-400. PubMed ID: 18974702
    [Abstract] [Full Text] [Related]

  • 4. Gene and stem cell therapy in peripheral arterial occlusive disease.
    Kalka C, Baumgartner I.
    Vasc Med; 2008 Oct; 13(2):157-72. PubMed ID: 18593804
    [Abstract] [Full Text] [Related]

  • 5. [Peripheral arterial occlusive disease and its care in hemodialysis patients].
    Chen HW, Liu HE.
    Hu Li Za Zhi; 2011 Apr; 58(2):16-21. PubMed ID: 21455888
    [Abstract] [Full Text] [Related]

  • 6. Medical treatment of peripheral arterial disease: a comprehensive review.
    Stoyioglou A, Jaff MR.
    J Vasc Interv Radiol; 2004 Nov; 15(11):1197-207. PubMed ID: 15525738
    [Abstract] [Full Text] [Related]

  • 7. [Autoantibodies and peripheral arterial occlusive disease].
    Kroeger K, Kreuzfelder E.
    Herz; 2004 Feb; 29(1):26-31. PubMed ID: 14968339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
    Davies MG, Waldman DL, Pearson TA.
    J Am Coll Surg; 2005 Aug; 201(2):275-96. PubMed ID: 16038827
    [No Abstract] [Full Text] [Related]

  • 10. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
    Kiesewetter H, Jung F, Birk A, Spitzer S.
    Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
    [Abstract] [Full Text] [Related]

  • 11. [Are the TASC recommendations for diagnosis and treatment of PAOD still relevant?].
    Langhoff R, Schulte KL.
    Hamostaseologie; 2006 Aug; 26(3):208-13. PubMed ID: 16906237
    [Abstract] [Full Text] [Related]

  • 12. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
    Unno N, Sakaguchi T, Nakamura T, Yamamoto N, Sugatani J, Miwa M, Konno H.
    J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
    [Abstract] [Full Text] [Related]

  • 13. Management of peripheral arterial disease.
    Gey DC, Lesho EP, Manngold J.
    Am Fam Physician; 2004 Feb 01; 69(3):525-32. PubMed ID: 14971833
    [Abstract] [Full Text] [Related]

  • 14. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW, Jaff MR.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):475-89. PubMed ID: 18307227
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I, Wysokin Ski W, Karnicki K, Adamiec R.
    Int Angiol; 2008 Aug 01; 27(4):296-301. PubMed ID: 18677291
    [Abstract] [Full Text] [Related]

  • 17. The role of exercise training in peripheral arterial disease.
    Milani RV, Lavie CJ.
    Vasc Med; 2007 Nov 01; 12(4):351-8. PubMed ID: 18048473
    [Abstract] [Full Text] [Related]

  • 18. [Anatomic distribution of peripheral atherosclerosis and its correlation with lipid disorders].
    Tesić DS.
    Med Pregl; 2009 Nov 01; 62 Suppl 3():75-9. PubMed ID: 19702121
    [Abstract] [Full Text] [Related]

  • 19. [Peripheral arterial disease: where are we in 2006?].
    Sraieb T, Bougamra S, Ben Romdhane N, Longo S, Manaa J.
    Tunis Med; 2007 May 01; 85(5):361-6. PubMed ID: 17657918
    [Abstract] [Full Text] [Related]

  • 20. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K, Ikeda U, Murakami Y, Yoshioka T, Shimada K.
    Am Heart J; 2003 Feb 01; 145(2):330-3. PubMed ID: 12595852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.